Two-year longitudinal study of parotid salivary flow rates in head and neck cancer patients receiving unilateral neck parotid-sparing radiotherapy treatment

Oral Oncology

Volumn 35, Issue 3, 1999, Pages 234-241

  Henson, B S ^a   Eisbruch, A ^a   D'Hondt, E ^a   Ship, J A ^a  

^a NONE

Author keywords

Cancer; Human; Longitudinal; Parotid; Preservation; Radiotherapy; Saliva; Xerostomia

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CELL DEATH; CLINICAL ARTICLE; FEMALE; FLOW RATE; HEAD AND NECK CANCER; HUMAN; INTERPHASE; LONGITUDINAL STUDY; MALE; PAROTID GLAND; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE; SALIVARY GLAND FUNCTION; SALIVATION; TREATMENT PLANNING; XEROSTOMIA;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PAROTID GLAND; SALIVA; XEROSTOMIA;

EID: 0033018759     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(98)00104-3     Document Type: Article

References (40)

1. Scully C, Epstein J.B. Oral health care for the cancer patient. European Journal of Cancer. Part B, Oral Oncology. 32B:1996;281-292.
2. Valdez I.H., Atkinson J.C., Ship J.A., Fox P.C. Major salivary gland function in patients with radiation-induced xerostomia: flow rates and sialochemistry. International Journal of Radiation Oncology, Biology, Physics. 25:1993;41-47.
3. Parsons JT. Time-dose-volume relation in radiation therapy. In: Million RR, Cassisi NJ, editors. Management of Head and Neck Cancer. A Multidisciplinary Approach. Philadelphia, PA: Lippincott Co., 1994:173-243.
4. Mandel I.D. The role of saliva in maintaining oral homeostasis. Journal of the American Dental Association. 119:(2):1989;298-304.
5. Young JA, Van Lennep EW. Transport in salivary and salt glands. In: Giebisch G, Tosteson DC, Ussing HH, editors. Membrane Transport in Biology. Berlin: Springer-Verlag, 1979:563-592.
6. Ship J.A., Fox P.C., Baum B.J. Normal salivary gland function: how much saliva is enough? Journal of the American Dental Association. 122:1991;63-69.
7. Stephens L.C., King G.K., Peters L.J., Ang K.K., Schultheiss T.E., Jardine J.H. Unique radiosensitivity of serous cells in rhesus monkey submandibular glands. American Journal of Pathology. 124:(3):1986;479-487.
8. Stephens L.C., Schultheiss T.E., Price R.E., Ang K.K., Peters L.J. Radiation apoptosis of serous acinar cells of salivary and lacrimal glands. Cancer. 67:(6):1991;1539-1543.
9. Jones R.E., Takeuchi T, Eisbruch A, Hazuka M, Ship J.A. Ipsilateral parotid sparing study in head and neck cancer patients receiving radiation therapy: 1 year results. Oral Surgery Oral Medicine Oral Pathology Oral Radiology Endodontics. 81:1996;642-648.
10. Greenspan D. Oral complications of cancer therapies. Management of salivary dysfunction. NCI Monographs. 9:1990;159-161.
11. Funegard U, Franzen L, Ericson T, Henriksson R. Parotid saliva composition during and after irradiation of head and neck cancer. European Journal of Cancer. Part B, Oral Oncology. 30B:1994;230-233.
12. Eneroth C.M., Henrikson C.O., Jakobsson P.A. Effect of fractionated radiotherapy on salivary gland function. Cancer. 30:(5):1972;1147-1153.
13. Eisbruch A, Ship J.A., Martel M.K., et al. Parotid gland sparing in patients undergoing bilateral head and neck irradiation: techniques and early results. International Journal of Radiation Oncology Biology Physics. 36:(2):1996;469-480.
14. Eisbruch A, Marsh L.H., Martel M.K., et al. Comprehensive irradiation of head and neck cancer using conformal multisegmental fields: assessment of target coverage and noninvolved tissue sparing. International Journal of Radiation Oncology, Biology, Physics. 41:(3):1998;559-568.
15. Mor V, Laliberte L, Morris J.N., Wiemann M. The Karnofsky Performance Status Scale. An examination of its reliability and validity in a research setting. Cancer. 53:(9):1984;2002-2007.
16. Ship J.A., Eisbruch A, D'Hondt E, Jones R.E. Parotid sparing study in head and neck cancer patients receiving bilateral radiation therapy: 1 year results. Journal of Dental Research. 76:1997;807-813.
17. Baum B.J. Evaluation of stimulated parotid saliva flow rate in different age groups. Journal of Dental Research. 60:(7):1981;1292-1296.
18. Heft M.W., Baum B.J. Unstimulated and stimulated parotid salivary flow rate in individuals of different ages. Journal of Dental Research. 63:(10):1984;1182-1185.
19. Hazuka M.B., Martel M.K., Marsh L, Lichter A.S., Wolf G.T. Preservation of parotid function after external beam irradiation in head and neck cancer patients: a feasibility study using 3-dimensional treatment planning. International Journal of Radiation Oncology, Biology, Physics. 27:(3):1993;731-737.
20. Stephens L.C., Ang K.K., Schultheiss T.E., King G.K., Brock W.A., Peters L.J. Target cell and mode of radiation injury in rhesus salivary glands. Radiotherapy & Oncology. 7:(2):1986;165-174.
21. Mira J.G., Wescott W.B., Starcke E.N., Shannon I.L. Some factors influencing salivary function when treating with radiotherapy. International Journal of Radiation Oncology, Biology, Physics. 7:(4):1981;535-541.
22. Leslie M.D., Dische S. The early changes in salivary gland function during and after radiotherapy given for head and neck cancer. Radiotherapy & Oncology. 30:(1):1994;26-32.
23. Makkonen T.A., Nordman E. Estimation of long-term salivary gland damage induced by radiotherapy. Acta Oncologica. 26:(4):1987;307-312.
24. Marks J.E., Davis C.C., Gottsman V.L., Purdy J.E., Lee F. The effects of radiation of parotid salivary function. International Journal of Radiation Oncology, Biology, Physics. 7:(8):1981;1013-1019.
25. Yagil C, Michaeli Y, Zajicek G. Compensatory proliferative response of the rat submandibular salivary gland to unilateral extirpation. Virchows Arch B, Cell Pathology. 49:(1):1985;83-91.
26. Schwartz-Arad D, Michaeli Y, Zajicek G. Compensatory hyperplasia of the rat submandibular gland following unilateral extirpation. Journal of Dental Research. 70:(10):1991;1328-1331.
27. Pabico R.C., McKenna B.A., Freeman R.B. Renal function before and after unilateral nephrectomy in renal donors. Kidney International. 8:(3):1975;166-175.
28. Ewald J, Aurell M. Renal function studies after donor nephrectomy. Scandinavian Journal of Urology & Nephrology. 29:1975;121-124.
29. Robbins M.E., Hopewell J.W., Golding S.J. Functional recovery in the irradiated kidney following removal of the contralateral unirradiated kidney. Radiotherapy & Oncology. 6:(4):1986;309-316.
30. Martinoli C, Derchi L.E., Solbiati L, Rizzatto G, Silvestri E, Giannoni M. Color Doppler sonography of salivary glands. American Journal of Roentgenology. 163:(4):1994;933-941.
31. Ahlner B.H., Lind M.G. The effect of irradiation on blood flow through rabbit submandibular glands. European Archives of Otorhinolaryngology. 251:(2):1994;72-75.
32. Jacobs C.D., van der Pas M. A multicenter maintenance study of oral pilocarpine tablets for radiation-induced xerostomia. Oncology. 10:(3 Suppl):1996;16-20.
33. Zimmerman R.P., Mark R.J., Tran L.M., Juillard G.F. Concomitant pilocarpine during head and neck irradiation is associated with decreased posttreatment xerostomia. International Journal of Radiation Oncology, Biology, Physics. 37:(3):1997;571-575.
34. Hamlar D.D., Schuller D.E., Gahbauer R.A., et al. Determination of the eflicacy of topical oral pilocarpine for postirradiation xerostomia in patients with head and neck carcinoma. Laryngoscope. 106:(8):1996;972-976.
35. Rieke J.W., Hafermann M.D., Johnson J.T., et al. Oral pilocarpine for radiation-induced xerostomia: integrated efficacy and safety results from two prospective randomized clinical trials. International Journal of Radiation Oncology, Biology, Physics. 31:(3):1995;661-669.
36. Davies A.N., Singer J. A comparison of artificial saliva and pilocarpine in radiation-induced xerostomia. Journal of Laryngology & Otology. 108:(8):1994;663-665.
37. Johnson J.T., Ferretti G.A., Nethery W.J., et al. Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer. New England Journal of Medicine. 329:(6):1993;390-395.
38. LeVeque F.G., Montgomery M, Potter D, et al. A multicenter, randomized, double-blind, placebo-controlled, dose-titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients. Journal of Clinical Oncology. 11:(6):1993;1124-1131.
39. Nagler R.M., Laufer D. Protection against irradiation-induced damage to salivary glands by adrenergic agonist administration. International Journal of Radiation Oncology, Biology, Physics. 40:(2):1998;477-481.
40. Buntzel J, Schuth J, Kuttner K, Glatzel M. Radiochemotherapy with amifostine cytoprotection for head and neck cancer. Supportive Care in Cancer. 6:(2):1998;155-160.